Cladribine as a therapeutic option in multiple sclerosis

被引：10
|
作者：
Warnke, Clemens [1 ]
Leussink, Verena I. [1 ]
Goebels, Norbert [1 ]
Aktas, Orhan [1 ]
Boyko, Alexey [2 ,3 ]
Kieseier, Bernd C. [1 ]
Hartung, Hans-Peter [1 ]
机构：
[1] Univ Dusseldorf, Dept Neurol, Fac Med, D-40225 Dusseldorf, Germany
[2] Russian State Med Univ, Dept Neurol & Neurosurg, Moscow 117437, Russia
[3] Moscow MS Ctr, Moscow, Russia
来源：
CLINICAL IMMUNOLOGY | 2012年 / 142卷 / 01期
关键词：
Cladribine; Multiple sclerosis; Immunosuppressant; Oral drugs; DOUBLE-BLIND; 2-CHLORODEOXYADENOSINE; TOXICITY; 2-CHLORO-2'-DEOXYADENOSINE; APOPTOSIS; TABLETS; SAFETY; CELLS; TRIAL;
D O I：
10.1016/j.clim.2011.05.009
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
There is an unmet need for more potent and convenient drugs in the treatment of patients diagnosed with multiple sclerosis (MS). Among five currently investigated oral drugs with an ongoing or completed phase III program, promising efficacy data for oral cladribine have recently been published. However, benefits need to be weighed against potential risks to define the role of this compound within current treatment regimens. Here we review present data on efficacy of oral cladribine and discuss known and anticipated risks of this drug. (C) 2011 Published by Elsevier Inc.
引用
收藏
页码：68 / 75
页数：8
相关论文
共 50 条
  • [41] Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
    Allen-Philbey, Kimberley
    De Trane, Stefania
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Mathews, Joela
    MacDougall, Amy
    Stennett, Andrea
    Zhou, Xia
    Yildiz, Ozlem
    Adams, Ashok
    Bianchi, Lucia
    Blain, Camilla
    Chapman, Christine
    Chung, Karen
    Constantinescu, Cris S.
    Dalton, Catherine
    Farrell, Rachel A.
    Fisniku, Leonora
    Ford, Helen
    Gran, Bruno
    Hobart, Jeremy
    Khaleeli, Zhaleh
    Mattoscio, Miriam
    Pavitt, Sue
    Pearson, Owen
    Peruzzotti-Jametti, Luca
    Scalfari, Antonio
    Sharrack, Basil
    Silber, Eli
    Tallantyre, Emma C.
    Webb, Stewart
    Turner, Benjamin P.
    Marta, Monica
    Gnanapavan, Sharmilee
    Juliusson, Gunnar
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [42] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [43] Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
    Schreiner, Teri L.
    Miravalle, Augusto
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2012, 4 : 1 - 14
  • [44] Cladribine and pregnancy in women with multiple sclerosis: The first cohort study
    Dost-Kovalsky, Karen
    Thiel, Sandra
    Ciplea, Andrea, I
    Gold, Ralf
    Hellwig, Kerstin
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (03) : 461 - 465
  • [45] Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis
    Zhu, Chao
    Zhou, Zhen
    Roos, Izanne
    Merlo, Daniel
    Kalincik, Tomas
    Ozakbas, Serkan
    Skibina, Olga
    Kuhle, Jens
    Hodgkinson, Suzanne
    Boz, Cavit
    Alroughani, Raed
    Lechner-Scott, Jeannette
    Barnett, Michael
    Izquierdo, Guillermo
    Prat, Alexandre
    Horakova, Dana
    Havrdova, Eva Kubala
    Macdonell, Richard
    Patti, Francesco
    Khoury, Samia Joseph
    Slee, Mark
    Karabudak, Rana
    Onofrj, Marco
    Van Pesch, Vincent
    Prevost, Julie
    Monif, Mastura
    Jokubaitis, Vilija
    van der Walt, Anneke
    Butzkueven, Helmut
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (12): : 1330 - 1337
  • [46] FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis
    Klatt, J.
    Hartung, H.-P.
    Hohlfeld, R.
    NERVENARZT, 2007, 78 (10): : 1200 - 1207
  • [47] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Hermann, Robert
    Karlsson, Mats O.
    Novakovic, Ana M.
    Terranova, Nadia
    Fluck, Markus
    Munafo, Alain
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 283 - 297
  • [48] Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy
    Ruggieri, Maddalena
    Gargano, Concetta Domenica
    Ferretta, Anna
    Manni, Alessia
    Capacchione, Antonio
    Frigeri, Antonio
    Iaffaldano, Pietro
    Trojano, Maria
    Paolicelli, Damiano
    BRAIN SCIENCES, 2020, 10 (08) : 1 - 13
  • [49] Multiple Sclerosis Therapeutic Pipeline: Opportunities and Challenges
    Krieger, Stephen
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (02): : 192 - 206
  • [50] Cladribine to Treat Relapsing Forms of Multiple Sclerosis
    Gavin Giovannoni
    Neurotherapeutics, 2017, 14 : 874 - 887
12345